Life Sciences Times

Future Family Names Alden Romney CEO, Founder Claire Tomkins Transitions to Executive Chair

Groups Names Cooper Zelnick as CEO to Lead Next Phase of Growth in Value-Based Addiction Care

MEDiC Life Sciences Acquires Clinical-Stage Oncology Program, Leveraging Biomarker Platform for Precision Medicine

AVS Expands with New Waltham Headquarters as It Prepares for U.S. Launch of PULSE IVL System

Aera Therapeutics Unveils Preclinical Data, Selects AERA-109 as First Development Candidate for Autoimmune Diseases

FDA Grants Priority Review to ENHERTU and Pertuzumab Combination for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

Pi Health Teams Up with GSK to Advance Global Clinical Research in Phase 2 Oncology Trial

Clean Harbors to Raise Used Oil Collection Prices Through Safety-Kleen Subsidiary

Actio Biosciences Doses First Participant in Phase 1 Trial of ABS-1230 for KCNT1-Related Epilepsy

Study Finds Sensus Healthcare’s SRT with Punch Excision Effective for Treating Keloids